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Programming Macrophage Inflammation Resolution: The Role of
Omega-3 Polyunsaturated Fatty Acids
Abstract
It was previously thought that resolution of inflammation was a passive process, but recent emerging research
has identified that resolution is an active process and that dual acting lipid mediators derived from essential
omega-3 polyunsaturated fatty acids (PUFAs) have both anti-inflammatory (reducing neutrophil access to the
inflamed tissue) and pro-resolving (removal of apoptotic cells by macrophages in the inflamed site) actions.
The objective of our study was to determine the role of omega-3 PUFAs in programming phenotypic changes
in treated macrophages. The polarization of macrophages during inflammatory responses to functionally
distinct phenotypes may play a role in both inflammation and resolution of inflammation following treatment
with omega-3 PUFAs for chronic inflammatory diseases.
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Introduction
The objective of our study was to determine the role of omega-3
polyunsaturated fatty acids in programming phenotypic changes in treated
macrophages
It was previously thought that resolution of inflammation was a passive process,
but recent emerging research has identified that resolution is an active process
and that dual acting lipid mediators derived from essential -3 PUFAs have both
anti-inflammatory (reducing neutrophil access to the inflamed tissue) and pro-
resolving (removal of apoptotic cells by macrophages in the inflamed site) actions.
Omega-3 PUFAs have anti-inflammatory and pro-resolving activity in pre-clinical
disease models (e.g. peritonitis, colitis, asthma)
Chronic inflammation is a key factor in the pathogenesis of numerous diseases (e.g.
COPD, RA, IBD)
The M2 Macrophage Phenotype
Role in allergic responses driven by Il-4 and IL-13
Involved in the development of TH2-dependent immune response to extracellular
parasites
M2 macrophages are associated with an anti-inflammatory state
DHA treatment reduces IL-6 production in product in LPS-stimulated
RAW264.7 macrophages
IL-6 production was measured in the supernatant fraction of treated cells by ELISA.
RAW264.7 macrophages were seeded at a density of 200,000 cells/ml and pre-treated
with the indicated concentrations (in μM) and combinations of ω-3 PUFAs ~18 hours
prior to a 24 hour LPS (1 μg/ml) stimulation. Data is represented as mean + SEM for
n=3. **p<0.01 versus LPS-treated cultures by one-way ANOVA; ***p<0.001 versus LPS-
treated cultures by one-way ANOVA. (DHA (500uM) + LPS = not detected by lower
sensitivity of assay.)
DHA drives polarization of alternatively activated (M2)
macrophages
Quantitative RT-PCR.  Total RNA was extracted from non-treated, LPS treated (500 
ng/ml), and DHA pre-treated (500 uM) RAW264.7 macrophages to measure 
mRNA levels of Arg-1 and FIZZ-1. Data is represented as mean + SEM for n=4.  
**p<0.01 versus LPS-treated cultures by one-way ANOVA; ***p<0.001 versus LPS-
treated cultures by one-way ANOVA.
Exposure to DHA following inflammatory insult attenuates COX-2
expression on LPS-stimulated RAW264.7 macrophages
Western blot: RAW264.7 macrophages were seeded at a density of 200,000 cells/ml
and pre-treated with DHA ~18 hours prior to a 24 hour LPS (500ng/ml) stimulation or
treated with DHA 30 minutes after LPS stimulation. Non-treated cultures were treated
with the same final concentration of ethanol as vehicle. Cell lysates were collected and
subjected to western blot analysis using an anti-COX-2, or anti-beta-tubulin antibody.
The antibody-specific bands were quantified by densitometry and were normalized to
beta-tubulin (numerical values above COX-2 band.) Blot shown is a representative
image from 3 independent experiments.
Conclusions
The action of ω-3 PUFAs drives the decrease in the proinflammatory mediator COX-2
and IL-6
M2 markers, Arg-1 and FIZZ1, are up-regulated in DHA treated macrophages
The polarization of macrophages during inflammatory responses to functionally
distinct phenotypes may play a role in both inflammation and resolution of
inflammation following treatment with ω-3 PUFAs.
Programming Macrophage Inflammation Resolution:
The role of omega-3 polyunsaturated fatty acids
Boris Krasnov, Mathew Lombardozzi, Maria Caraballo, and Ramil Sapinoro, Ph.D.
St. John Fisher College, Wegmans School of Pharmacy, Rochester, NY
R
/A
V
/S
R
/S
0.0
0.5
1.0
1.5
2.0
2.5 **
**, p<0.01, n=4
A
R
G
-1
R
/A
V
/S
R
/S
0
1
2
3
4
***
***, p<0.001. n=4.
F
IZ
Z
-1
NT       LPS      LPS
+
DHA  
NT       LPS      LPS
+
DHA  
